Study guide

21.3 Pleural Effusions and Arrhythmias

Certified Pediatric Hematology Oncology Nurse CPHON®

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy

2 Care Continuum

2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship

3 Leukemias and Lymphomas

3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas

4 CNS, Neuroblastoma, and Renal Tumors

4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors

5 Sarcomas and Other Solid Tumors

5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors

6 Hematologic Disorders

6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure

7 Pathophysiology, Genetics, and Diagnostics

7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis

8 Clinical Trials and Professional Performance

8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education

9 Chemotherapy and Biotherapy

9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy

10 Immunotherapy, Cellular Therapy, and Radiation

10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam

11 HSCT, Surgery, Transfusion, and Coagulation Therapy

11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy

12 Neurologic, Respiratory, and Cardiovascular Effects

12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects

13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects

13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects

14 Endocrine, Hematologic, Immunologic, and Sensory Effects

14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects

15 Pain, Sleep, Fatigue, and Mental Health

15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects

16 Supportive Care

16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care

17 Infectious and Gastrointestinal Emergencies

17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction

18 Metabolic Emergencies

18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome

19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome

19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)

20 Sickle Cell and Hemostasis Emergencies

20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed

21 Cardiopulmonary Emergencies

21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias

22 Neurologic and Infusion Emergencies

22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation

23 Family, Caregivers, and Social Integration

23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment

24 Development, Grief, Culture, and Community Resources

24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources

21.3 Pleural Effusions and Arrhythmias

Key Takeaways Explain This Topic AI

Malignant effusion, chylothorax after thoracic surgery, and infection all present with dyspnea and decreased breath sounds; confirm with upright chest radiograph and/or ultrasound.

Thoracentesis or a chest tube relieves distress; do not drain massive volumes instantly in small children without monitoring, because re-expansion pulmonary edema is a pediatric risk.

Arrhythmia triggers in this population include tumor-lysis hyperkalemia, anthracyclines, arsenic-trioxide QTc prolongation, uncommon high-dose 5-HT3-antagonist QTc effects, and fever-related sinus tachycardia.

Put at-risk children on telemetry, replete or treat electrolytes, keep a crash cart available, and hold QT-prolonging medicines when QTc is already long.

New bradycardia with hypertension or irregular respirations is a signpost of increased intracranial pressure, not a primary arrhythmia to treat with atropine as the only move.

Last updated: August 2026

CPHON TCO V.E.3–4 tests pleural effusions and arrhythmias as cardiopulmonary emergencies. Domain IV already covered bleomycin lung, chyle as a lymphatic effect, anthracycline cardiomyopathy, and QTc monitoring as late-effect work. This section is the acute drain and the acute rhythm: get the fluid off safely , put the child on telemetry , and know when bradycardia is increased intracranial pressure (ICP) , not a primary heart problem.

A 5-year-old drowning in a malignant effusion, an 8-year-old with milky chest-tube output after thoracic neuroblastoma surgery, and a child with peaked T waves on tumor-lysis morning are the pictures. Generic names only: doxorubicin , daunorubicin , arsenic trioxide , ondansetron . Brand antiemetics and brand anthracyclines do not appear on ONCC items.

Pleural effusions: three sources, one respiratory exam

Three high-yield sources share dyspnea and decreased breath sounds :

Malignant effusion — lymphoma (especially T-lymphoblastic and Hodgkin), leukemia, metastatic solid tumors. Fluid may be the presenting finding and, as the mediastinal-mass section taught, a safer diagnostic specimen than a sedated central biopsy.

Chylothorax — thoracic-duct injury after mediastinal or chest surgery (thoracic neuroblastoma, selected lymphoma or germ-cell resections, occasional line or thoracotomy complications). Output is milky and triglyceride-rich , often lymphocyte-predominant.

Infection — parapneumonic effusion, empyema, or effusion during fever and neutropenia. Do not assume every effusion is malignant in a neutropenic child with pneumonia, and do not assume every febrile effusion is “only infection” when a mediastinal mass is sitting next to it.

Confirm with upright chest radiograph and/or bedside ultrasound . A supine portable film underestimates layering fluid. Infants feed poorly, grunt, and prefer to sit. Do not skip imaging because “the lung sounds a little soft.”

Thoracentesis or chest-tube drainage relieves distress and can diagnose. Nursing is positioning (upright or as tolerated—except the mediastinal-mass child who cannot lie flat), oxygen, pain control, and monitoring output character and volume.

Do not drain massive volumes instantly in small children without monitoring. Rapid evacuation of a large collection can cause re-expansion pulmonary edema , violent cough, hypoxia, and hemodynamic swings. Controlled drainage, pause if the child crashes, and intensive-care backup for a huge effusion in a toddler are the CPHON moves. ONCC does not publish a single milliliter-per-kilogram stop number as exam fact. The principle is controlled drainage and reassessment , not a race to empty the bottle because the intern wants a dry film before rounds.

Chylothorax after the drain: respiratory support, chest-tube care, nutrition as ordered ( low long-chain fat , medium-chain triglyceride formulas, or parenteral nutrition), and sometimes octreotide . Persistent leak is a surgical conversation. Do not strip the tube harder because milky output looks thick, and do not start a high-fat celebration diet the night of surgery.

Malignant fluid may reaccumulate until the cancer is treated. The drain is a bridge; chemotherapy, corticosteroids, or radiation treat the source. Infection needs antibiotics and sometimes video-assisted drainage for loculated empyema—team decisions after you have protected breathing.

Walk the 5-year-old. Decreased breath sounds, oxygen 88%, upright film with a white-out hemithorax, ultrasound showing a large free collection. The plan is oxygen, controlled tube or catheter drainage with monitoring, and a sample to cytology and culture—not a single massive syringe pull to “get it all now,” and not a trip to the playroom until the lung is heard again.

Arrhythmias: electrolytes, drugs, fever, and the ICP signpost

Put the child on telemetry when tumor lysis, arsenic, a wide-complex rhythm, syncope, or a crashing potassium is in play. Keep a crash cart on the unit and know the code-button path. Hold QT-prolonging medicines when QTc is already long.

High-yield pediatric oncology triggers:

Tumor-lysis hyperkalemia — peaked T waves, widened QRS, sine-wave risk. This is the metabolic-emergency playbook: no potassium in fluids, insulin-glucose , cardioprotective calcium , dialysis. Arrhythmia here is a potassium emergency, not a lidocaine-first puzzle. Hypokalemia and hypomagnesemia, conversely, seed ectopy and torsades when arsenic or a 5-HT3 antagonist is on board.

Anthracyclines ( doxorubicin , daunorubicin ) — acute pericarditis or arrhythmia during infusion blocks, and later cardiomyopathy that seeds ventricular arrhythmia. New ectopy after an anthracycline day is not “anxiety from being in the hospital.”

Arsenic trioxide — classic QTc prolongation and torsades risk in acute promyelocytic leukemia (APL). Replete potassium and magnesium , obtain protocol electrocardiograms, and hold arsenic when the team’s QTc threshold is crossed. Do not invent a single millisecond cutoff as ONCC fact; use the protocol in front of you.

5-hydroxytryptamine-3 (5-HT3) antagonists such as intravenous ondansetron — QTc prolongation is uncommon but real at higher intravenous doses , especially when stacked with arsenic, low potassium, or other QT-active drugs. Hold or change the antiemetic when QTc is already long. Do not stack a large rapid ondansetron bolus onto a prolonged QTc because “everyone gets it before chemotherapy.”

Fever — sinus tachycardia is expected. Do not treat sinus tach from fever as ventricular tachycardia and do not charge a defibrillator for a febrile sinus rate. Do treat the fever workup (sepsis chapter).

Bradycardia from increased ICP is the signpost that saves a life. Cushing physiology is hypertension, bradycardia, and irregular respirations . A 7-year-old with a posterior-fossa or other brain tumor whose heart rate falls while blood pressure rises is herniation physiology , not a primary sinoatrial problem and not “the child is finally calm after morphine.” Escalate the neurologic-emergency pathway: airway, head of bed, urgent team, osmotherapy as ordered. Do not treat that bradycardia with atropine as the only move and go back to charting. Full ICP algorithms live in the next emergency chapter; this chapter’s job is to refuse to mislabel the rhythm.

  • Problem Clue Nursing move
  • Malignant effusion Dyspnea, decreased sounds, cancer Upright CXR/US; controlled drain; treat the cancer

Chylothorax Milky, triglyceride-rich after chest surgery Tube care; low-fat or parenteral nutrition; octreotide as ordered

  • Infected effusion Fever, neutropenia, pneumonia Antibiotics; drainage as ordered
  • Rapid huge tap in a toddler Re-expansion edema risk Controlled drainage; monitor
  • TLS potassium Peaked T, wide QRS Telemetry; TLS hyperkalemia pathway
  • Arsenic or high-dose 5-HT3 Long QTc Electrolytes; hold QT-prolonging meds
  • Fever Sinus tachycardia Treat the cause; do not shock sinus tach
  • Increased ICP Bradycardia plus hypertension Signpost neuro emergency; do not atropine-and-ignore

The CPHON product is a toddler whose effusion was drained in a controlled way, a chyle tube that was named chyle, a QTc that stopped the next ondansetron bolus, a potassium that was treated as a cardiac emergency, and a falling heart rate that was called ICP rather than a quiet, reassuring pulse.

Loading diagram... Effusion drain control and arrhythmia fork, including ICP bradycardia

Teaching emphasis for arrhythmia watch (relative priority, not incidence)